Cerebrospinal fluid Aβ40 is similarly reduced in patients with Frontotemporal Lobar Degeneration and Alzheimer's Disease-Reference-Cited by-同舟云学术

Cerebrospinal fluid Aβ40 is similarly reduced in patients with Frontotemporal Lobar Degeneration and Alzheimer's Disease

Published:2015-11 Issue:1-2 Volume:358 Page:308-316
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Baldeiras Inês^ORCID,Santana Isabel,Leitão Maria João,Ribeiro Maria Helena,Pascoal Rui,Duro Diana,Lemos Raquel,Santiago Beatriz,Almeida Maria Rosário,Oliveira Catarina Resende

Funder

Portuguese Foundation for Science and Technology

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology

Reference95 articles.

1. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS;Al-Sarraj;Acta Neuropathol.,2011

2. Diagnostic and Statistical Manual of Mental Disorders, 4 rd ed;American Psychiatric Association,1994

3. Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients;Baldeiras;J. Neurol.,2009

4. Clinical dementia rating (CDR);Berg;Psychopharmacol. Bull.,1988

5. CSF biomarkers in frontotemporal lobar degeneration with known pathology;Bian;Neurology,2008

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling Alzheimer’s Disease: Investigating Dynamic Functional Connectivity in the Default Mode Network through DCC-GARCH Modeling;2024-06-03

2. CRISPR-Powered Aptasensor for Diagnostics of Alzheimer’s Disease;ACS Sensors;2023-12-28

3. Alzheimer's disease and inflammatory biomarkers positively correlate in plasma in the UK‐ADRC cohort;Alzheimer's & Dementia;2023-11-27

4. Biomarkers in frontotemporal dementia: Current landscape and future directions;Biomarkers in Neuropsychiatry;2023-06

5. How far is the goal of applying β-amyloid in cerebrospinal fluid for clinical diagnosis of Alzheimer’s disease with standardization of measurements?;Clinical Biochemistry;2023-02